Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility of Intranasal Insulin in Patients With Spinal Cord Injury

NCT07384052 is registered in ClinicalTrials.gov with HealthPartners Institute as lead sponsor.

NCT NCT07384052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07384052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility of Intranasal Insulin in Patients With Spinal Cord Injury
Lead sponsor
HealthPartners Institute
Phase
Phase 1
Overall status
Recruiting
Start date
February 20, 2026
Completion date
January 31, 2027
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spinal cord injury